Coya Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.1M | $4.8M | $4.3M |
| FY2022 | $16.8M | $8.4M | $5.9M |
| FY2023 | $5.6M | $41.3M | $32.6M |
| FY2024 | $4.8M | $44.3M | $38.3M |
| FY2025 | $6.9M | $50.0M | $46.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.1M | $4.8M | $4.3M |
| FY2022 | $16.8M | $8.4M | $5.9M |
| FY2023 | $5.6M | $41.3M | $32.6M |
| FY2024 | $4.8M | $44.3M | $38.3M |
| FY2025 | $6.9M | $50.0M | $46.8M |